Washington, Feb. 9 -- Rep. Hakeem Jeffries issued the following press release: Today, House Democratic Leader Hakeem Jeffries (D-NY) and Senate Democratic Leader Chuck Schumer (D-NY) released the fol... Read More
Washington, Feb. 9 -- Representative Gabe Vasquez issued the following press release: On February 6, 2026, U.S. Representative Gabe Vasquez (NM-02) visited La Pinon Sexual Assault Recovery Services i... Read More
Washington, Feb. 9 -- Representative Gabe Vasquez issued the following press release: U.S. Representative Gabe Vasquez (NM-02) rolled out a bipartisan bill to transform the bureaucratic federal permi... Read More
Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ACTRN12626000162314) titled 'Comparative Efficacy of Budesonide and Fexofenadine in Seasonal Allerg... Read More
Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ACTRN12626000160336) titled 'Keeping Your New Kidney Healthy by Evaluating Body Composition and Gly... Read More
Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ACTRN12626000161325) titled 'Efficacy of oral health education intervention to improve oral hygiene... Read More
Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ACTRN12626000163303) titled 'Mapping Musculoskeletal Pain Distribution in Hepatitis C: An Observati... Read More
Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ISRCTN74685186) titled 'Behavioural activation on haemodialysis' on Feb. 9. Study Type: Interventi... Read More
Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ISRCTN15100098) titled 'Good Life with Dementia Feasibility Study' on Feb. 9. Study Type: Interven... Read More
Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ISRCTN10574179) titled 'Astria STAR-0215-302 trial for Navenibart in Hereditary Angioedema' on Feb.... Read More